Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Aileen Wilson"'
Autor:
Patrick G Kehoe, Nicholas Turner, Beth Howden, Lina Jarutyt, Shona L Clegg, Ian B Malone, Josephine Barnes, Casper Nielsen, Carole H Sudre, Aileen Wilson, N Jade Thai, Peter S Blair, Elizabeth J Coulthard, J Athene Lane, Peter Passmore, Jodi Taylor, Henk-Jan Mutsaerts, David L Thomas, Nick C Fox, Ian Wilkinson, Yoav Ben-Shlomo
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 8, Iss 19 (2021)
Background: Medications that modify the renin–angiotensin system may reduce Alzheimer’s disease pathology and reduce the rate of disease progression. Objective: This study investigated whether taking the antihypertensive drug losartan, in additio
Externí odkaz:
https://doaj.org/article/81e153bea7a84db597fe5cde3dbfd1f0
Autor:
Froso Sophocleous, Estefania De Garate, Maria Giulia Bigotti, Maryam Anwar, Eva Jover, Aranzazu Chamorro-Jorganes, Cha Rajakaruna, Konstantina Mitrousi, Viola De Francesco, Aileen Wilson, Serban Stoica, Andrew Parry, Umberto Benedetto, Pierpaolo Chivasso, Frances Gill, Mark C. K. Hamilton, Chiara Bucciarelli-Ducci, Massimo Caputo, Costanza Emanueli, Giovanni Biglino
Publikováno v:
Cells, Vol 11, Iss 23, p 3721 (2022)
Bicuspid aortic valve (BAV) patients develop ascending aortic (AAo) dilation. The pathogenesis of BAV aortopathy (genetic vs. haemodynamic) remains unclear. This study aims to identify regional changes around the AAo wall in BAV patients with aortopa
Externí odkaz:
https://doaj.org/article/1e1ef6f261454ce09245229e4a94597d
Autor:
Elanor C. Hinton, Laura A. Birch, John Barton, Jeffrey M. P. Holly, Kalina M. Biernacka, Sam D. Leary, Aileen Wilson, Olivia S. Byrom, Julian P. Hamilton-Shield
Publikováno v:
BMC Pediatrics, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Slowing eating rate using the Mandolean® previously helped obese adolescents to self-select smaller portion sizes, with no reduction in satiety, and enhanced ghrelin suppression. The objective of this pilot, randomised trial was
Externí odkaz:
https://doaj.org/article/a8d72058fa7140fea1813270b8bdc606
Autor:
Aileen Wilson
Publikováno v:
Art Education. 75:15-20
Autor:
Nimra Naeem, Rebecca Elsworth, Kruthika Narayan, Fiona Lithander, Ruth Elson, Tashunka Taylor-Miller, Aileen Wilson, Julian Hamilton-Shield, Elizabeth Crowne, Elanor Hinton
Publikováno v:
British Society of Paediatric Endocrinology and Diabetes.
Autor:
Patrick Gavin Kehoe, Nicholas Turner, Beth Howden, Lina Jarutyte, Shona Louise Clegg, Ian Brian Malone, Josephine Barnes, Casper Nielsen, Carole Hélène Sudre, Aileen Wilson, Ngoc Jade Thai, Peter Sinclair Blair, Elizabeth Coulthard, Janet Athene Lane, Peter Passmore, Jodi Taylor, Henk-Jan Mutsaerts, David Lee Thomas, Nick Charles Fox, Ian Wilkinson, Yoav Ben-Shlomo, Kirsty Harkness, Tarun Kuruvilla, Rupert McShane, Peter Connelly, Gordon Duncan, Lucy Calvert, Alasdair Lawrie, Matthew Sheridan, Eric Jackson, Bernard Udeze, Stephen Pearson, Tobias Langheinrich, Suvarna Wagle, Joseph Butchart, Ajay Macharouthu, Andrew Donaldson, Wendy Neil, Vivek Pattan, David Findlay, Alan Thomas, Robert Barber, Andrew Byrne, Madhusudan Dalvi, Rashi Negi, Bernadette McGuinness
Publikováno v:
The Lancet. Neurology
Lancet Neurology, 20(11), 895-906. Lancet Publishing Group
Kehoe, P G, Turner, N, Howden, B, Jarutyte, L, Clegg, S L, Malone, I B, Barnes, J, Nielsen, C, Sudre, C H, Wilson, A, Thai, N J, Blair, P S, Coulthard, E, Lane, J A, Passmore, P, Taylor, J, Mutsaerts, H-J, Thomas, D L, Fox, N C, Wilkinson, I, Ben-Shlomo, Y & RADAR investigators 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial) : a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422(21)00263-5
RADAR investigators 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial ', The Lancet. Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422(21)00263-5
2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial) : a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422(21)00263-5
Kehoe, P G, Turner, N, Howden, B, Jarutyte, L, Clegg, S L, Malone, I B, Barnes, J, Nielsen, C, Sudre, C H, Wilson, A, Thai, N J, Blair, P S, Coulthard, E, Lane, J A, Passmore, P, Taylor, J, Mutsaerts, H-J, Thomas, D L, Fox, N C, Wilkinson, I & Ben-Shlomo, Y 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 .
Lancet Neurology, 20(11), 895-906. Lancet Publishing Group
Kehoe, P G, Turner, N, Howden, B, Jarutyte, L, Clegg, S L, Malone, I B, Barnes, J, Nielsen, C, Sudre, C H, Wilson, A, Thai, N J, Blair, P S, Coulthard, E, Lane, J A, Passmore, P, Taylor, J, Mutsaerts, H-J, Thomas, D L, Fox, N C, Wilkinson, I, Ben-Shlomo, Y & RADAR investigators 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial) : a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422(21)00263-5
RADAR investigators 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial ', The Lancet. Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422(21)00263-5
2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial) : a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 . https://doi.org/10.1016/S1474-4422(21)00263-5
Kehoe, P G, Turner, N, Howden, B, Jarutyte, L, Clegg, S L, Malone, I B, Barnes, J, Nielsen, C, Sudre, C H, Wilson, A, Thai, N J, Blair, P S, Coulthard, E, Lane, J A, Passmore, P, Taylor, J, Mutsaerts, H-J, Thomas, D L, Fox, N C, Wilkinson, I & Ben-Shlomo, Y 2021, ' Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial ', Lancet Neurology, vol. 20, no. 11, pp. 895-906 .
BACKGROUND: Drugs modifying angiotensin II signalling could reduce Alzheimer's disease pathology, thus decreasing the rate of disease progression. We investigated whether the angiotensin II receptor antagonist losartan, compared with placebo, could r
Autor:
Giovanni Biglino, Aileen Wilson, Giulia Bigotti, Chiara Bucciarelli-Ducci, K Mitrousi, Pierpaolo Chivasso, Costanza Emanueli, Viola de Francesco, Mark Hamilton, Maryam Anwar, Cha Rajakaruna, Froso Sophocleous, Eva Jover Garcia, Estefania De Garate, Aranzazu Chamorro-Jorganes, Massimo Caputo
Publikováno v:
Abstracts.
Publikováno v:
British Journal of Nursing. 27:1180-1185
Quality clinical placements for pre-registration nursing students are particularly important at a time when there is a recruitment crisis within nursing. A study was conducted to identify what impact clinical placements have on pre-registration adult
Autor:
Aileen Wilson, Elanor C. Hinton, Olivia S Byrom, Sam D Leary, Julian P Hamilton-Shield, Jeffrey M P Holly, Laura Birch, John Barton, Kalina Biernacka
Publikováno v:
BMC Pediatrics, Vol 18, Iss 1, Pp 1-10 (2018)
Hinton, E C, Birch, L A, Barton, J S, Holly, J M P, Biernacka, K M, Leary, S D, Wilson, A, Byrom, O S & Hamilton-Shield, J P 2018, ' Using neuroimaging to investigate the impact of Mandolean® training in young people with obesity : a pilot randomised controlled trial ', BMC Pediatrics, vol. 18, no. 1, 366 . https://doi.org/10.1186/s12887-018-1342-1
BMC Pediatrics
Hinton, E C, Birch, L A, Barton, J S, Holly, J M P, Biernacka, K M, Leary, S D, Wilson, A, Byrom, O S & Hamilton-Shield, J P 2018, ' Using neuroimaging to investigate the impact of Mandolean® training in young people with obesity : a pilot randomised controlled trial ', BMC Pediatrics, vol. 18, no. 1, 366 . https://doi.org/10.1186/s12887-018-1342-1
BMC Pediatrics
Background: Slowing eating rate using the Mandolean® previously helped obese adolescents to self-select smaller portion sizes, with no reduction in satiety, and enhanced ghrelin suppression. The objective of this pilot, randomised trial was to inves
Autor:
Tashunka Taylor-Miller, Kruthika Narayan, Elizabeth Crowne, Nimra Naeem, Ruth Elson, Aileen Wilson, Rebecca Elsworth, Elanor C. Hinton, Fiona E Lithander, Julian P Hamilton-Shield
Publikováno v:
Appetite. 169:105564